Science Explorer Interactive view Map
Company · Warsaw · Poland

AstraZeneca (Poland)

In research, AstraZeneca (Poland) stands highest in Medicine (#4,639 of 10,443 worldwide) and Health Sciences (#5,827 of 11,982 worldwide), 2022–2025.

astrazeneca.plROR OpenAlex
World rank, 2022–2025
#8,952
of 28,054 · #13,037 all time
Rank in Poland
#95
of 318
Research works
428
▲ 144% vs 2013–17
Citations
9.7k
22.6 per fractional work
Top-10% rate
23.2%
record average 16.5%
Open access
54%
world 28%

What is AstraZeneca (Poland) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,639 of 10,443 28.0%73 #8646
Health SciencesDomain #5,827 of 11,982 27.4%77 #11118

Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (Poland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.75× its world share, 36 worksBiochemistry, Geneti…Immunology and Microbiology: 3.42× its world share, 6 worksImmunology and Micro…Neuroscience: 0.28× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.93× its world share, 5 worksPharmacology, Toxico…Chemical Engineering: 0.53× its world share, 0 worksChemical EngineeringChemistry: 6.74× its world share, 19 worksChemistryComputer Science: 0.28× its world share, 4 worksComputer ScienceEarth and Planetary Sciences: 0.12× its world share, 0 worksEarth and Planetary …Energy: 0.05× its world share, 0 worksEnergyEngineering: 0.36× its world share, 10 worksEngineeringEnvironmental Science: 0.59× its world share, 5 worksEnvironmental ScienceMaterials Science: 0.73× its world share, 5 worksMaterials ScienceMathematics: 0.92× its world share, 2 worksMathematicsPhysics and Astronomy: 0.12× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.68× its world share, 3 worksHealth ProfessionsMedicine: 2.13× its world share, 73 worksMedicineNursing: 0.58× its world share, 0 worksNursingVeterinary: 0.54× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Decision Sciences: 0.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.00× its world share, 4 worksEconomics, Econometr…Psychology: 0.18× its world share, 1 worksPsychologySocial Sciences: 0.08× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.9×. Every wedge is a field page.

Which keywords describe research at AstraZeneca (Poland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Chemotherapy, Medicinal Chemistry, Biopharmaceuticals, Immunogenicity and Monoclonal Antibody.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology12▲ 1.69×39 topics
  2. Monoclonal Antibodies11▲ 69×3 topics
  3. Therapeutic Antibodies10▲ 76×2 topics
  4. Chemotherapy9▲ 7.1×16 topics
  5. Glycosylation9▲ 44×3 topics
  6. Inflammation9▲ 2.4×39 topics
  7. Medicinal Chemistry8▲ 15×9 topics
  8. Biopharmaceuticals7▲ 78×3 topics
  9. Immunogenicity7▲ 90×2 topics
  10. Monoclonal Antibody7▲ 72×2 topics
  11. Clinical Trials7▲ 5.6×12 topics
  12. Treatment6▲ 2.8×15 topics
  13. Nanoparticles6▲ 2.7×15 topics
  14. Diagnosis6▲ 3.5×16 topics
  15. Targeted Therapy6▲ 14×4 topics
  16. Cardiovascular Disease6▲ 2.9×20 topics
  17. Recombinant Proteins6▲ 100×2 topics
  18. Cell Culture5▲ 26×3 topics
  19. Protein Aggregation5▲ 57×1 topic
  20. Stability5▲ 13×1 topic
  21. Global Burden5▲ 5.5×5 topics
  22. Management5▲ 3.5×12 topics
  23. Biopharmaceutical Production4▲ 61×2 topics
  24. Breast Cancer4▲ 11×7 topics
  25. Mammalian Cells4▲ 102×1 topic
  26. Recombinant Protein4▲ 102×1 topic
  27. Antibody Engineering4▲ 42×1 topic
  28. Fc Receptors4▲ 42×1 topic
  29. Heart Failure4▲ 5.3×12 topics
  30. Asthma4▲ 23×2 topics
  31. Treatment Guidelines4▲ 10×3 topics
  32. Pharmacokinetics4▲ 8.2×5 topics
  33. Drug Discovery4▲ 9.6×6 topics
  34. Genomic Profiling4▲ 20×2 topics
  35. Immunology4▲ 20×2 topics
  36. Glycemic Control4▲ 13×4 topics
  37. ALK Inhibitors4▲ 31×1 topic
  38. Chronic Kidney Disease4▲ 8.0×7 topics
  39. EGFR Mutations4▲ 31×1 topic
  40. Allergic Diseases3▲ 33×1 topic

Which research topics does AstraZeneca (Poland) publish most on?

By volume in 2022–2025: Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.

Protein purification and…5Protein purification and stability: 5 fractional worksViral Infectious Disease…4Viral Infectious Diseases and Gene Expression in Insects: 4 fractional worksMonoclonal and Polyclona…4Monoclonal and Polyclonal Antibodies Research: 4 fractional worksLung Cancer Treatments a…4Lung Cancer Treatments and Mutations: 4 fractional worksAsthma and respiratory diseases: 3 fractional worksComputational Drug Discovery Methods: 3 fractional worksChronic Obstructive Pulm…3Chronic Obstructive Pulmonary Disease (COPD) Research: 3 fractional worksHER2/EGFR in Cancer Rese…2HER2/EGFR in Cancer Research: 2 fractional worksInnovative Microfluidic …2Innovative Microfluidic and Catalytic Techniques Innovation: 2 fractional worksDrug Solubulity and Deli…2Drug Solubulity and Delivery Systems: 2 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory MedicinePhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein purification and stability Molecular Biology 5 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 4 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  5. 5 Asthma and respiratory diseases Physiology 3 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 3 works
  8. 8 HER2/EGFR in Cancer Research Oncology 2 works
  9. 9 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 2 works
  10. 10 Drug Solubulity and Delivery Systems Pharmaceutical Science 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.5%not open46.5%

World: 28% of research is openly available.

with international co-authors87.2%domestic only12.8%

World: 19% is written across borders.

How has AstraZeneca (Poland)'s research output changed?

Output in 2018–2022 was 144% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warsaw

All research institutions in Warsaw

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.